1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Yifeng Pharmacy Chain Co., Ltd.

Yifeng Pharmacy Chain Co., Ltd.

603939.SS
Yifeng Pharmacy Chain Co., Ltd.CN flagShanghai Stock Exchange
20.11
CNY
-0.03
- -
24.38BMarket Cap
Yifeng Pharmacy Chain Co., Ltd.
603939.SS
(Shanghai Stock Exchange)

Recent

price

20.11

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1.68
2.09
2.47
3.06
3.02
3.62
4.33
6.21
8.92
11.36
12.84
16.55
18.72
19.83
20.09
19.77
Revenue per Share
0.08
0.09
0.14
0.19
0.19
0.22
0.28
0.37
0.47
0.64
0.74
1.05
1.17
1.26
1.38
1.33
Basic EPS, GAAP
-0.13
-0.02
0.14
0.16
0.02
-0.11
0.1
0.25
0.44
1.51
1.11
2.77
3.22
2.92
2.5
-0.44
Free Cash Flow per Basic Share
0.04
- -
0.03
0.07
0.08
- -
0.05
0.16
0.14
0.14
0.18
0.2
0.27
0.7
0.7
0.85
Dividend per Share
0.21
0.3
0.4
0.52
0.7
0.89
1
1.27
1.59
2.18
2.86
3.69
4.79
5.42
6.04
5.74
Book Value per Share
0.34
0.43
0.52
0.65
1.14
2.21
2.07
1.07
1.14
1.69
3.14
3.7
4.44
5.06
5.86
5.45
Tangible Book Value per Share
727
736
731
728
944
1,033
1,109
1,113
1,152
1,157
1,193
1,202
1,207
1,213
1,216
1,215
Basic Weighted Avg Shares
1,224
1,539
1,804
2,230
2,846
3,734
4,807
6,913
10,276
13,145
15,326
19,886
22,588
24,062
24,433
24,022
Sales/Revenue/Turnover
6.03
6.02
7.42
8.41
7.71
7.59
8.4
7.9
8.41
9.76
9.51
10.19
9.45
9.64
10.29
10.12
Operating Margin (%)
- -
15
21
22
27
38
50
70
95
942
1,191
1,441
1,649
1,883
1,750
- -
Depreciation Expense
56
69
99
141
176
224
314
416
544
744
888
1,262
1,412
1,529
1,678
1,611
Net Income, GAAP
26.88
25.37
25.71
25.57
25.61
25.48
25.84
24.03
25.23
25.54
25.95
24.18
22.41
24.27
25.46
24.89
Effective Tax Rate (%)
4.56
4.46
5.5
6.3
6.18
6
6.52
6.02
5.29
5.66
5.79
6.35
6.25
6.35
6.87
6.71
Profit Margin (%)
123
125
186
242
728
1,926
1,799
1,345
1,261
1,795
1,171
919
859
3,258
5,073
4,060
Working Capital
- -
- -
- -
- -
- -
- -
- -
746
687
3,743
2,390
2,180
2,339
3,914
3,256
3,727
LT Debt
356
426
502
596
1,419
2,975
3,180
4,170
4,709
5,663
7,865
9,119
10,447
11,394
12,379
11,885
Total Equity
- -
16.46
20.56
24.33
15.73
9.43
9.57
9.92
12.04
11.7
9.76
12.68
12.12
11.17
10.97
10.79
Return on Invested Capital (%)
- -
33.43
37.93
41.05
31.2
27.41
30.13
23.19
20
13.37
12.24
15.73
14.64
13.82
13.19
13.04
Return on Capital (%)
- -
36.66
38.96
42.25
33.84
28.24
30.89
32.98
33.44
34.15
29.94
32.14
27.62
24.73
24.1
24.31
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
1,367
1,298
1,174
LT Borrowings
1,601
1,614
1,626
LT Finance Leases
2,313
2,108
2,100
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,212
1,212
1,212
Market Capitalization
29,742
30,262
29,727

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
15,856
15,876
14,700
Cash, Cash Equivalents & STI
7,986
8,501
7,751
Accounts Receivable, Net
2,124
1,832
1,600
Inventories
4,528
4,372
4,235
Total Current Liabilities
12,598
12,103
10,640
Payables & Accruals
- -
- -
- -
ST Debt
1,367
1,298
1,174
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
26.79%
17.42%
8.65%
Free Cash Flow
-29.77%
24.23%
-14.22%
Net Income, GAAP
25.89%
18.3%
9.81%
Sales/Revenue/Turnover
24.83%
13.6%
1.54%
Total Cash Common Dividend
- -
48.07%
0.33%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,971
5,791
5,456
6,843
24,062
2025
6,009
5,713
7,147
- -
24,433
2026
6,085
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.33
- -
- -
- -
1.26
2025
0.37
- -
- -
- -
1.38
2026
0.41
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.7
2025
- -
- -
- -
- -
0.7
2026
0.01
- -
- -
- -
- -
Similar Companies
Kanabo Group Plc (KNB.L)
Cellid, Co., Ltd. (299660.KQ)
Leafly Holdings, Inc. (LFLYW)
Empreendimentos Pague Menos S.A. (PGMN3.SA)
Sandu Pharmaceuticals Limited (SANDUPHQ.BO)
Public Joint-Stock Company Pharmacy Chain 36.6 (APTK.ME)
Business
Yifeng Pharmacy Chain Co., Ltd. (603939:SHH) operates as a leading pharmaceutical retail chain in China, primarily engaged in the retailing and wholesaling of pharmaceuticals, health products, medical devices, and related consumer goods through an extensive network of stores and digital channels. The company offers Western and Chinese patent medicines, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, convenience products related to health, maternal and child products, daily necessities, and household cleaning products; it also provides chronic disease management services, medical project investment, medical technology development, internet hospital operations, franchise distribution, and e-commerce platforms. Yifeng Pharmacy Chain maintains a significant presence across Central South China, East China, and North China, including provinces such as Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing, with approximately 40,000 employees supporting over 6,000 stores. Founded in 2001 and headquartered at No. 68 Jinzhou Avenue, Lugu High-Tech Zone, Changsha, China, the company listed on the Shanghai Stock Exchange in 2015 and operates through its key subsidiary, Hunan Yifeng Pharmaceutical Co., Ltd., for wholesale activities. In recent developments, Yifeng Pharmacy Chain completed the acquisition of a 51% stake in Hunan Jiuzhitang Pharmaceutical Co., Ltd. from Jiuzhitang Co., Ltd.; it achieved a net increase of 2,512 stores in 2024 through a city-specific strategy of new openings, mergers and acquisitions, and franchising while closing inefficient outlets; the company upgraded its electronic prescription transfer services, integrated over 4,600 pharmacies with outpatient medical insurance systems, established partnerships with nearly 200 specialized prescription drug suppliers, and enhanced its digital platform interfacing with over 50 hospital systems including internet hospitals.